It would be relevant to investigate if these signaling pathways are similarly activated in breast cancer cells, as a better knowledge of the molecular determinants associated with the H19 and miR-675 phenotypes in breast cancer progression would provide new therapeutic opportunities. Here, H19 is linked to breast carcinoma.